LeadIQ logo
Learn more at LeadIQ.com

Insights

Loading spinner
Gathering insights about Glyscend Therapeutics…

Glyscend Therapeutics Tech Stack

Glyscend Therapeutics uses 8 technology products and services including Open Graph, RSS, Webpack, and more. Explore Glyscend Therapeutics's tech stack below.

  • Open Graph
    Content Management System
  • RSS
    Content Management System
  • Webpack
    Development
  • JSON-LD
    Javascript Frameworks
  • Modernizr
    Javascript Libraries
  • Choices
    Javascript Libraries
  • WPBakery
    Page Builders
  • PHP
    Programming Languages

Media & News

Glyscend Therapeutics's Email Address Formats

Glyscend Therapeutics uses at least 1 format(s):
Glyscend Therapeutics Email FormatsExamplePercentage
FLast@glyscend.comJDoe@glyscend.com
43%
First@glyscend.comJohn@glyscend.com
7%
FLast@glyscend.comJDoe@glyscend.com
43%
First@glyscend.comJohn@glyscend.com
7%

Frequently Asked Questions

Where is Glyscend Therapeutics's headquarters located?

Minus sign iconPlus sign iconGlyscend Therapeutics's main headquarters is located at 600 Suffolk Street Suite 250 Lowell, Massachusetts 01854 United States. The company has employees across 1 continents, including North America.

What is Glyscend Therapeutics's official website and social media links?

Minus sign iconPlus sign iconGlyscend Therapeutics's official website is glyscend.com and has social profiles on LinkedInCrunchbase.

What is Glyscend Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign iconGlyscend Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Glyscend Therapeutics have currently?

Minus sign iconPlus sign iconAs of February 2026, Glyscend Therapeutics has approximately 8 employees across 1 continents, including North America. Key team members include Co Founder: P. J. P.Independent Consultant: B. S.Medical Doctor: M. H.. Explore Glyscend Therapeutics's employee directory with LeadIQ.

What industry does Glyscend Therapeutics belong to?

Minus sign iconPlus sign iconGlyscend Therapeutics operates in the Biotechnology Research industry.

What technology does Glyscend Therapeutics use?

Minus sign iconPlus sign iconGlyscend Therapeutics's tech stack includes Open GraphRSSWebpackJSON-LDModernizrChoicesWPBakeryPHP.

What is Glyscend Therapeutics's email format?

Minus sign iconPlus sign iconGlyscend Therapeutics's email format typically follows the pattern of FLast@glyscend.com. Find more Glyscend Therapeutics email formats with LeadIQ.

How much funding has Glyscend Therapeutics raised to date?

Minus sign iconPlus sign icon As of February 2026, Glyscend Therapeutics has raised $20M in funding. The last funding round occurred on Jun 11, 2020 for $20M.

When was Glyscend Therapeutics founded?

Minus sign iconPlus sign iconGlyscend Therapeutics was founded in 2014.

Glyscend Therapeutics

Biotechnology ResearchMassachusetts, United States2-10 Employees

Developer of oral, gut-targeted polymer therapeutics for the treatment of metabolic indications such as type 2 diabetes, and other chronic conditions. The company is developing a lead drug, which is orally administered, non-absorbed, gut-restricted duodenal exclusion therapy designed to replicate the metabolic effects of bariatric surgery with safety-advantages avoiding invasive complications of surgeries and procedures.

Section iconCompany Overview

Headquarters
600 Suffolk Street Suite 250 Lowell, Massachusetts 01854 United States
Website
glyscend.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2014
Employees
2-10

Section iconMedia & News

Section iconFunding & Financials

  • $20M

    Glyscend Therapeutics has raised a total of $20M of funding over 5 rounds. Their latest funding round was raised on Jun 11, 2020 in the amount of $20M.

  • $1M

    Glyscend Therapeutics's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $20M

    Glyscend Therapeutics has raised a total of $20M of funding over 5 rounds. Their latest funding round was raised on Jun 11, 2020 in the amount of $20M.

  • $1M

    Glyscend Therapeutics's revenue is estimated to be in the range of $1M

Company Leadership

  • Stylized image of a person
    P. J. P.
    Co Founder
    Phone icon
    Mobile Phone
  • Stylized image of a person
    B. S.
    Independent Consultant
    Phone icon
    Mobile Phone
  • Stylized image of a person
    M. H.
    Medical Doctor
    Phone icon
    Mobile Phone

Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.